Bcl-6, encoded by the BCL6 gene, was initially discovered as an oncogene in B-cell lymphomas, driving a malignant phenotype via the repression of DNA damage and proliferation checkpoints [31]. Here, BCL6 is linked to B-cell non-Hodgkin lymphoma.